T

Theravance Biopharma
D

TBPH

9.80000
USD
0.21
(2.14%)
مغلق
حجم التداول
8,245
الربح لكل سهم
1
العائد الربحي
-
P/E
-10
حجم السوق
481,908,101
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACOR
    -0.26810
    (-30.48%)
    0.61160 USD
    A
    ALKS
    -0.260
    (-0.87%)
    29.490 USD
    C
    CRBP
    0.180
    (1.39%)
    13.140 USD
    F
    FOLD
    0.02000
    (0.20%)
    9.83000 USD
    G
    GLPG
    0.350
    (1.31%)
    27.080 USD
    I
    INSM
    0.100
    (0.14%)
    70.540 USD
    P
    PTCT
    -0.660
    (-1.43%)
    45.540 USD
    S
    SAGE
    -0.18000
    (-3.21%)
    5.43000 USD
    S
    SRPT
    1.570
    (1.32%)
    120.540 USD
    المزيد
الأخبار
المقالات

العنوان: Theravance Biopharma

القطاع: Healthcare
الصناعة: Biotechnology
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).